Related Experiment Video
Updated: Jul 14, 2026
10:20
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
Metabolic changes in exercise-induced and methacholine-induced bronchoconstriction
The Journal of Allergy and Clinical Immunology
|June 1, 1976
Summary
Asthma patients with exercise-induced bronchoconstriction show unique metabolic responses to challenges. Free fatty acid levels rise differently after methacholine and exercise, suggesting distinct physiological pathways in this asthma subgroup.
Area of Science:
- Exercise physiology
- Pulmonary medicine
- Biochemistry
Background:
- Asthma is a chronic respiratory condition characterized by airway inflammation.
- Exercise-induced bronchoconstriction (EIB) is a common asthma exacerbation trigger.
- Understanding metabolic differences in asthma subtypes is crucial for targeted therapies.
Purpose of the Study:
- To compare metabolic and physiological responses to exercise and methacholine challenge in asthmatics with and without EIB.
- To identify potential biomarkers differentiating asthma phenotypes.
Main Methods:
- Recruitment of asthmatic patients categorized by the presence or absence of EIB.
- Administration of graded treadmill exercise and methacholine challenge.
- Measurement of plasma free fatty acids and lactic acid, ventilation, and oxygen consumption.
Main Results:
- Free fatty acid levels significantly increased post-methacholine challenge only in asthmatics with EIB.
- Free fatty acid levels increased in both asthmatic groups following treadmill exercise.
- No significant alterations in plasma lactic acid, ventilation, or oxygen consumption were observed across groups.
Conclusions:
- Asthmatics with EIB exhibit distinct metabolic profiles compared to asthmatics without EIB, particularly in response to methacholine.
- Free fatty acid response may serve as a potential indicator for differentiating asthma phenotypes.
- Further research is warranted to elucidate the specific metabolic pathways involved in EIB.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...